Back to Blackstone Inc

Blackstone Inc

All holdings · as of Mar 31, 2026

415 positions

CompanyClassValueShares% of portfolio
CITIGROUP INC$4.97M43,8560.0%
Applied Digital Corp$5.01M211,1100.0%
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTDTSMADR$5.03M14,8850.0%
CONCENTRA GROUP HOLDINGS PAR$5.05M235,2220.0%
Apple Hospitality REIT, Inc.$5.14M446,9000.0%
SHOPIFY INC$5.16M43,5240.0%
Lexeo Therapeutics, Inc.$5.19M904,9590.0%
Western Digital Corp$5.23M19,3520.0%
KIMBERLY CLARK CORP$5.28M54,7180.0%
TARGET CORP$5.28M43,5690.0%
BP PLC$5.34M113,5950.0%
Fidelity National Information Services Inc$5.48M116,7720.0%
ABBOTT LABORATORIES$5.54M53,9150.0%
First Solar Inc$5.63M28,5560.0%
Moody's Corp$5.80M13,3050.0%
GENERAL ELECTRIC CO$5.88M20,7140.0%
FOX CORP$6.04M103,4620.0%
BRITISH AMERN TOB PLC$6.25M106,8880.0%
OXFORD LANE CAP CORP$6.60M675,0000.0%
Jones Lang LaSalle Inc$6.80M22,3290.0%
TransDigm Group Inc.$6.86M5,9150.0%
Delek Logistics Partners LP$6.88M138,3250.0%
KLARNA GROUP PLC$6.88M525,8440.0%
S&P Global Inc.$7.10M16,6910.0%
BULLISH$7.15M200,0000.0%
PROGRESSIVE CORP/OH$7.49M37,7840.0%
General Motors Co$7.69M103,1790.0%
LUMENTUM HLDGS INC$7.83M11,1380.0%
EchoStar CORP$7.84M66,9270.0%
ASSEMBLY BIOSCIENCES, INC.ASMBCommon Stock$8.24M296,8550.0%
FS Credit Opportunities Corp.FSCOClosed-End Fund$8.48M1,662,9450.0%
Union Pacific Corp$8.55M35,2560.0%
Suburban Propane Partners LP$8.68M440,9360.0%
Definium Therapeutics, Inc.DFTXCommon Stock$9.61M508,6680.0%
Alphabet Inc.$9.80M34,0780.0%
Compass Therapeutics, Inc.$9.83M1,857,8480.0%
Inhibikase Therapeutics, Inc.$9.98M5,938,2760.0%
BOSTON SCIENTIFIC CORP$10.08M160,6170.0%
Global Partners LP$10.13M240,7170.0%
KARBON CAP PARTNERS CORP$10.19M1,000,0000.0%
Genesis Energy LP$10.27M575,7350.0%
X4 Pharmaceuticals, Inc$11.08M2,681,9220.0%
ALX Oncology Holdings Inc.$11.71M5,826,5440.0%
Protara Therapeutics, Inc.$11.80M2,265,5140.0%
Mastercard Inc$12.13M24,2800.1%
Terns Pharmaceuticals, Inc.$12.19M231,2820.1%
Chatham Lodging Trust$12.76M1,621,0000.1%
ARRAY TECHNOLOGIES INC$13.01M1,799,9000.1%
DAMORA THERAPEUTICS INC$13.04M503,5220.1%
SPYRE THERAPEUTICS, INC.$14.77M292,8470.1%
← PrevPage 7 of 9Next →